tiprankstipranks
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
US Market
BLTE
Belite Bio, Inc. ADR
RESEARCH TOOLSreports

Belite Bio, Inc. ADR (BLTE) Income Statement

59 Followers

Belite Bio, Inc. ADR Income Statement

Last quarter (Q4 2025), Belite Bio, Inc. ADR's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Belite Bio, Inc. ADR's net income was $-25.32M. See Belite Bio, Inc. ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ -198.00K$ -30.00K
Operating Expenses
$ 84.21M$ 40.00M$ 31.67M$ 12.82M$ 9.80M
Depreciation and Amortization
$ 0.00$ 449.00K$ 399.00K$ 198.00K$ 30.00K
EBITDA
$ -84.21M$ -35.67M$ -31.20M$ -12.43M$ -9.64M
Operating Income
$ -84.21M$ -40.00M$ -31.67M$ -12.82M$ -9.80M
Other Income/Expenses
$ 6.60M$ 3.86M$ 45.00K$ 173.00K$ 131.00K
Pretax Income
$ -77.61M$ -36.14M$ -31.62M$ -12.65M$ -9.67M
Net Income
$ -77.61M$ -36.14M$ -31.63M$ -12.65M$ -9.67M
Per Share Metrics
Basic EPS
$ -2.31$ -1.18$ -1.19$ -0.63$ -0.40
Diluted EPS
$ -2.31$ -1.18$ -1.19$ -0.63$ -0.40
Weighted Average Shares Outstanding
 33.54M 30.54M 26.59M 19.98M 24.10M
Weighted Average Shares Outstanding (Diluted)
 33.54M 30.54M 26.59M 19.98M 24.10M
Currency in USD

Belite Bio, Inc. ADR Earnings and Revenue History